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Abstract
Physical training induces beneficial adaptation, whereas exhaustive exercises increase reactive oxygen-species
generation,therebycausingoxidativedamageinplasmaanderythrocytes,fractionssusceptibletolipidperoxidation.
Pequi(CaryocarbrasilienseCamb.)isaBrazilianCerradofruitcontainingacarotenoid-richoil.Theaimwastoinves-
tigate the effects of pequi-oil on exercise-induced oxidative damage in plasma and erythrocytes, after running in the
same environment and undergoing weekly training under the same conditions as to type, intensity and length. Evalu-
ations were accomplished after outdoor running on flat land before and after ingestion of 400 mg pequi-oil capsules
for 14 days. Blood samples were taken after running and submitted to TBARS assay and erythrogram analysis.
Haptoglobin, MnSOD (Val9Ala), CAT (21A/T) and GPX1 (Pro198Leu) gene polymorphisms were priorly investi-
gated, so as to estimate genetic influence The reduction in erythrocytes, hemoglobin and hematocrit after pequi-oil
treatment was notably associated with higher plasma expansion. Except for MCHC (mean corpuscular hemoglobin
concentration) and RDW (red cell distribution width), the results were influenced by the polymorphisms studied. The
bestresponsetopequi-oilwaspresentedbyMnSODVal/Val,CATAAorATgenotypesandtheGPX1Proallele.The
significantly lower RDW and higher MHCH values were related to pequi-oil protective effects. Pequi oil, besides pos-
sessing other nutritional properties, showed protective blood effects.
Key words: Caryocar brasiliense Camb., hemogram, hematimetric indexes (MCV, MCH, MCHC and RDW), haptoglobin and
antioxidant enzyme polymorphisms.
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Introduction
Cells continuously produce reactive oxygen species
(ROS), mainly as a result of normal oxidative metabolism
in the mitochondria (Hermes-Lima, 2004). Under normal
circumstances, ROS are neutralized by an elaborate anti-
oxidant defence system, consisting of enzymes such as
catalase (CAT), superoxide dismutase (SOD), glutathione
peroxidase (GPX) and numerous non-enzymatic antioxi-
dants (Hermes-Lima, 2004; Ferreira et al., 2007). Strenu-
ous physical activity increases oxygen consumption and
can produce an imbalance between ROS and antioxidants,
inducing oxidative stress as a result of increased ROS pro-
duction (Ji, 1995; Sureda et al., 2005). Acutely, intense ex-
ercise is a well accepted model to induce oxidative stress
(Alessio, 1993; Ji, 1995), leading to an increase in plasma
lipidperoxidation(ClarksonandThompson,2000;Ferreira
et al., 2007). Exhaustive exercise can induce oxidative
damage in blood cells and plasma, which are the most sus-
ceptible fractions to suffer from exercise-induced lipid oxi-
dative damage (Sureda et al., 2005).
Exercise results in increased amounts of malon-
dialdehyde (MDA) in the blood, which serve as indirect in-
dicators of lipid peroxidation and can be measured by
TBARS assay (Wasowicz et al., 1993; Clarkson and
Thompson, 2000; Ferreira et al., 2007). Lipid and protein
oxidation induced by high-intensity exercise have previ-
ously been clearly demonstrated (Alessio, 1993; Ji, 1995);
erythrocytes are very sensitive to oxidative stress, because
theyareunabletorepairdamagedcomponents,suchaspro-
teins, by re-synthesis (nucleus absence), and their mem-
branes are vulnerable to peroxidative damage, besides their
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Research Articlepoor repair mechanism (Cazzola et al., 2003; Sureda et al.,
2005).
On the other hand, a condition referred to as “sports
anemia” has been observed in athletes, especially endur-
ance athletes, who presented low-normal hematologic val-
ues (red blood cells, hemoglobin, hematocrit) (Carlson and
Mawdsley, 1986; Eichner, 1998). However this is a false
anemia”, since regular aerobic exercises expand the vol-
ume of baseline plasma, thereby diluting red blood cells
(RBC) and hemoglobin (Hb) concentration (Eichner,
1998). In other words, the naturally lower hematologic val-
ues of an endurance athlete are a dilutional pseudoanemia,
which is an adaptation to the acute loss of plasma volume
that occurs in initial stages of exercise (Carlson and
Mawdsley, 1986; Eichner, 1998). Due to the early reduc-
tion in plasma volume, the organism releases renin, aldos-
teroneandvasopressin;asafinalresult,thebaselineplasma
volume expands (Carlson and Mawdsley, 1986; Eichner,
1998; Petibois and Déléris, 2005).
The most common true anemia in athletes is iron-
deficiency anemia, which occurs mainly in women athletes
(Petibois and Déléris, 2005). However, hemolysis can also
occur, as a result of mechanical trauma in the capillaries of
runners’ feet (Carlson and Mawdsley, 1986). In this case,
extracellular Hb becomes highly toxic because of the oxi-
dativecapacityofiron-containingheme,whichparticipates
in the Fenton reaction to produce reactive oxygen species
and causes cell injuries (Wassel, 2000; Guéye et al., 2006).
Hence, haptoglobin (Hp), a serum glycoprotein, functions
as an antioxidant by virtue of its ability to bind to hemoglo-
bin and thereby to prevent Hb-induced oxidative damage
(Tseng et al., 2004; Guéye et al., 2006). It has been demon-
stratedthattheprotectiveeffectofHpagainstthisoxidative
mechanism is also phenotype dependent (Guéye et al.,
2006).
Furthermore, many potentially significant genetic
variantsrelatedtooxidativestresshavealreadybeenidenti-
fied, including single nucleotide polymorphisms (SNPs),
Val9Ala in the mitochondrial targeting sequence of the
MnSODgene(NCBI,refSNPID:rs1799725),21A/Tinthe
promoter region of the CAT gene (NCBI, refSNP ID:
rs7943316), and Pro198Leu of the GPX1 gene (NCBI,
refSNP ID: rs1050450), besides others (Mitrunen et al.,
2001; Ukkola et al., 2001; Morgenstern, 2004; Zhao et al.,
2005). The effect of these variations has not yet been clari-
fied;however,mostofthepolymorphismsresultinchanges
in the levels or the activities of these enzymes, which can
lead to reduction in protection against oxidative stress
(Bastaki et al., 2006).
Pequi (Caryocar brasiliense Camb.) is a typical tree
found in the Brazilian Cerrado, the fruit of which is well
known in regional cookery, in popular medicine and for its
high nutritional value. Since pequi fruit-pulp-oil contains
several carotenoids such as -carotene, lycopene, -caro-
tene, cryptoflavin, -cryptoxanthine, anteraxanthine, zea-
xanthine, mutatoxanthine, violanxanthine, lutein and neo-
xanthine (Ramos et al., 2001; Azevedo-Meleiro and Rodri-
guez-Amaya, 2004; Oliveira et al., 2006; Lima et al.,
2007), the aim of this study was to investigate the protec-
tive effects of pequi oil against exercise-induced damages
in plasma and RBC, after races in the same environment
and the same type, intensity and length of weekly training
conditions. To estimate if the antioxidant effects of pequi
oil were influenced by antioxidant enzyme genotypes, the
MnSOD (Val9Ala), CAT (21A/T) and GPX1 (Pro198Leu)
genes’ polymorphisms were investigated.
Materials and Methods
Study design and participants
The trial was conducted from August 2007 to April
2008, after preclinical and toxicological tests in mice (Mi-
randa-Vilela et al., 2008). Volunteers of both genders (74
men and 45 women) and different age groups (15 to 67)
were recruited in high schools, colleges, universities, clubs
and companies in Brasília (Federal District). The selection
criterion used for the runners was that they had at least a
4,000 m run performance; they were to participate in two
races,before(controlgroup)andafter(treatmentgroup)in-
gestionof400mgofpequioilincapsulessupplieddailyfor
14 consecutive days. The choice of this daily ingestion pro-
tocol took into account the data from pequi literature and
the maximum daily dose of provitamin A carotenoids
(25mg)recommendedbytheNationalAgencyforSanitary
Surveillance (ANVISA).
The races took place outdoors on flat land, under the
same environmental conditions, and the athletes could
choose the distance that they would cover (4, 5, 6, 7, 8, 10,
16, 19, 21 km), according to their type, intensity and length
of weekly training, guaranteed that it would be the same in
the two races. The time needed to finish the races was veri-
fied and it was the same in both race, thus guaranteeing the
same intensity (time needed to finish the race) before and
after pequi oil supplementation. The volunteers were in-
formed about the purpose of the study; all of them received
a computer-generated random number and were free to
withdraw at any time during the study. After the first race,
they received the capsules and were instructed to take them
for 14 days during or immediately after lunch until the sec-
ond race.
The protocol was approved by the Research Ethics
Committee for the Health Sciences Faculty of the Univer-
sity of Brasília and by the National Commission for Ethics
in Research (CONEP), number 0.001668/2005-18. Written
informed consent was obtained from all subjects.
Preparation of the capsules
Pequifruitwasobtainedinnaturafromthelocalmar-
kets of Brasília/DF (Brazil) and surrounding areas. The in-
ternal mesocarp was peeled or grated to obtain the pulp,
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Pequi pulp-oil was extracted by cold maceration using
chloroformasasolvent.Theextractwassubmittedtoevap-
oration under reduced pressure for solvent recovery, and
dried at high vacuum. The oil was then incorporated into
Aerosil’s (colloidal silicon dioxide) q.s.p., guaranteeing in-
gestion of a daily 400 mg dose. Relative composition is
shown in Table 1. The production process was patented as
numberPI0601631-6(NationalInstituteofIndustrialProp-
erty - INPI).
Procedures and measurements
Blood samples were drawn with EDTA immediately
after races in two rounds: (1) running without pequi-oil
supplementation and (2) running after ingestion of 400 mg
of pequi oil in capsules supplied daily for 14 consecutive
days.BloodsampleswereusedtocountRBCandforgeno-
typing of haptoglobin and antioxidant enzymes, while se-
rum samples were submitted to TBARS assay.
RBC counting and TBARS assay
RBC counting was carried out in an automated Cell-
Dyn 3700 analyzer (Abbott Diagnostics), using internal
(Cell-Dyn 22) and external (Program of Excellence for
Medical Laboratories - PEML) controls. Values of erythro-
cytes, hemoglobin, hematocrit and hematimetric indexes
(mean cell volume or MCV; mean cell hemoglobin or
MCH; mean corpuscular hemoglobin concentration or
MCHC; and red cell distribution width or RDW) were esti-
matedandtheirreferencevalueswerelistedinTable2.The
TBARSassaywascarriedoutaccordingtoWasowiczetal.
(1993), and the fluorescence was measured with a Jasco
FP-777 spectrofluorometer (excitation: 525 nm, emission:
547 nm).
Haptoglobin (Hp) and antioxidant enzymes
genotyping
DNAwasisolatedfromthebuffy-coatlayerusingthe
GFX purification kit (GE Healthcare, Buckinghamshire,
England).Hpgenotypesweredeterminedbyallele-specific
PCR (Polymerase Chain Reaction) as described by Yano et
al. (1998), while Mn-SOD, CAT and GPX1 genotypes
were determined by polymerase chain reaction (PCR)-
based restriction fragment length polymorphism (RFLP)
assays performed as described respectively by Mitrunen et
al.(2001),Ukkolaetal.(2001)andZhaoetal.(2005).PCR
and PCR-based RFLP products were resolved in non-
denaturing polyacrylamide gels stained with silver nitrate.
Statistical analysis
To reveal contingent differences between the groups
involved, statistical significance was assessed by T-test for
dependent samples. Statistical analysis was carried out us-
ing SPSS (Statistical Package for the Social Sciences) ver-
sion 17.0 and SAS (Statistical Analysis System) version
9.1.3, service pack 3. Data were expressed as mean  SE
(standard error of mean) and values of p < 0.05 were con-
sidered statistically significant. The statistical factors ana-
lyzed were total and gender groups, age (15-19, 20-24,
25-29, 30-34, 35-39, 40-44 and 45 year-olds up) and dis-
tance covered (4-5, 6-7, 8-10 and 16-21 km).
The influence of Hp, MnSOD, CAT and GPX1 geno-
types (genetic markers) was investigated through the fol-
lowingANOVAmodel:Yijk=+i+j+()ij+eijk,where
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Table 1 - Relative composition of pequi (Caryocar brasiliense Camb.)
pulp-oil capsules. Omega (), which is defined according to carbon nu-
meration associated with the first double bonds (3rd, 6th, 7th or 9th) from
the methyl group, is correlated to unsaturated fatty acids.
Fatty acids
1
Saturated Carbon number Quantity (% per 100 g
of pequi pulp fruit)
Palmitic C16:0 41.78
Stearic C18:0 1.28
Araquidic C20:0 0.12
Total 43.18
Unsaturated
Mono-unsaturated
Oleic C18:1 (9) 54.28
Palmitoleic C16:1 (7) 0.67
Bi-unsaturated
Linoleic C18:2 (6) 1.36
Tri-unsaturated
Linolenic C18:3 (3) 0.51
Total 56.82
Carotenoids
2 Quantity (mg/100 g of
pequi pulp fruit)
Provitamin A 6.26-11.5
Lycopene 1.12-2.08
Total 6.75-28.66
1Miranda-Vilela et al, 2009 and present study.
2Ramose ta l ., 2001; Azevedo-Meleiro and Rodriguez-Amaya, 2004;
Oliveirae ta l ., 2006; Limae ta l ., 2007.
Table 2 - Reference values of RBC and hematimetric index
Hemogram Reference values
Men Women
Erythrocytes (millions/mm
3) 4.50 to 6.10 4.00 to 5.40
Hemoglobin (g/dL) 13.0 to 16.5 12.0 to 15.8
Hematocrit (%) 36.0 to 54.0 33.0 to 47.8
MCV (fl = femtoliters) 80.0 to 98.0 80.0 to 98.0
MCH (pg = picograms) 26.8 to 32.9 26.2 to 32.6
MCHC (g/% or g/dL) 32.0 to 36.0 32.0 to 36.0
RDW (%) 12.0 to 14.5 12.0 to 14.5
g/dL = grams per deciliter; g/% = grams per percentage. is the general mean, i the pequi-oil effect, j the effect of
the analyzed variable and eijk the random error, which must
present normal distribution with mean zero and constant
variance. The Fisher LSD test was used to verify differ-
ences between the variable categories (genotypes).
Allelic and genotypic frequencies were estimated by
genecountingandthegoodnessoffitofthegenotypedistri-
bution for to Hardy-Weinberg equilibrium (HWE) was
tested by chi-square (	
2 test). Values of p > 0.05 were con-
sideredinHWEandweregeneratedbyGenepopwebstatis-
tical program version 3.4.
Results
RBC counting
After supplementation, there was a general down-
ward trend for erythrocytes, hemoglobin, hematocrit and
anisocytosis (RDW values), accompanied by an increase in
MCV,MCHandMCHCvalues;allofthemwereinsidethe
reference values (Table 3). Results of the total group were
significant for erythrocytes (p = 0.0007), hematocrit
(p = 0.0011) and RDW (p = 0.0000), which decreased, as
well as for MCH (p = 0.0001) and MCHC (p = 0.0002),
which increased. For women, there was a significant de-
crease in erythrocytes (p = 0.0453) and hematocrit
(p=0.0305)andasignificantincreaseinMCH(p=0.0116)
and MCHC (p = 0.0081). Men presented a significant de-
cline in erythrocytes (p = 0.0068), hematocrit (p = 0.0246)
and RDW (p = 0.0000), and a significant enhancement of
MCH (p = 0.0066) and MCHC (p = 0.0316). Significant
RDW reductions were observed in age groups of 15-19,
35-39 and 40-44 years. The second group presented also a
significant increase in the MCH (p = 0.0084) and MCHC
(p = 0.0379) values after pequi-oil treatment (Table 4). The
significant drop in erythrocyte and hematocrit values, al-
though observed for the group as a whole, was particularly
related to the age groups 15-19 and 25-29, and distances of
4-5 and 8-10 km. For these distances, there was also a sig-
nificant increase in MCH (p = 0.0467 and p = 0.0003,
respectively) and MCHC (p = 0.0308 and p = 0.0011, re-
spectively) values. RDW values decreased significantly at
almost all distances after supplementation, except for
16-21 km (Table 5).
The ANOVA model indicated that results of erythro-
cytes were influenced by Hp (p = 0.0040) and CAT
(p = 0.0003) polymorphisms; hemoglobin by GPX1
(p=0.0234)polymorphism,hematocritbyHp(p=0.0048),
MnSOD (p = 0.0053) and CAT (p = 0.0009)
polymorphisms; MCV by CAT (p = 0.0047) and GPX1
(p = 0.0230) polymorphisms; and MCH by CAT
(p = 0,0006) and GPX1 (p = 0.0402) polymorphisms (Fig-
ure 1). Concerning MCHC and RDW values, the ANOVA
model indicated that these hematimetric indexes were in-
fluenced only by the pequi oil treatment; that is, the MCHC
and RDW values were not influenced by the gene’s poly-
morphism.
TBARS assay
After pequi-oil supplementation, there was a non-
significant drop in those values specifically related to men,
withnoeffectbeingobservedinwomen.Significantvalues
appearedforMDAincreasedat4-5km(p=0.0427)andfor
MDAdecreasedat6-7km(p=0.0034);theresultswerein-
fluenced by Hp (p = 0.0008) and MnSOD (p = 0.0072)
polymorphisms (Figure 2).
Genetic marker analysis
Table 6 summarizes the distribution of Haptoglobin,
MnSOD,CATandGPX1allelefrequencies,thegeneticdi-
versity parameters, the genotype frequencies and the
Hardy-Weinberg equilibrium (HWE) data for chi-square
(	
2) test. Results indicated a significant deviation from
Hardy-Weinbergequilibrium(HWE)fortheMnSODlocus
(p = 0.0000), with a heterozygote excess (p = 0.0000).
MnSOD locus presented a heterozygosity-observed (Ho)
value higher than the heterozygosity-expected (He) value,
and an FIS (inbreeding coefficient) value (FIS = 0.6302)
compatible with selection in favour of heterozygotes. The
genotypic distributions of Hp, CAT and GPX1 loci were in
accordance with HWE.
Adverse effects
No subjects withdrew from the study because of dis-
comfort or adverse effects associated with the treatment.
Eleven subjects experienced heavy drowsiness, while four
reported insomnia; six volunteers had a mild intestinal dis-
order, two constipation, and three increased flatulence, one
man complained of heartburn, two women reported in-
creased acne and one woman described the appearance of
painful subcutaneous nodules on the arms. All these symp-
toms were noticed within the first 3 to 4 days of treatment,
disappearing soon afterwards.
Discussion
Athletes, especially distance runners, tend to develop
a condition known as sports anemia or pseudoanemia,
whichprovokestemporaryreductioninhematologicvalues
(red blood cells, hemoglobin and hematocrit) as a result of
plasma volume expansion (Carlson and Mawdsley, 1986;
Eichner, 1998). Such transitory reductions are a beneficial
physiological adaptation to aerobic exercises (Carlson and
Mawdsley, 1986; Eichner, 1998; Petibois and Déléris,
2005), since they decrease the resistance of blood flow, im-
prove sweating and increase ejection volume of the heart
(Eichner,1998).Sincethenaturallylowerhematologicval-
ues of endurance athletes is a dilutional pseudoanemia, the
“footstrike” hemolysis that occurs as a result of mechanical
traumainthecapillariesofrunners’feetisunlikelytocause
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.anemia (Carlson and Mawdsley, 1986; Eichner, 1998).
Therefore, the most common true anemia in athletes is due
to iron-deficiency, which occurs mainly in women (Eich-
ner, 1998). By sweating, athletes generally lose amounts of
iron, which should be supplied by the diet. The principal
cause of iron-deficiency in athletic women is insufficient
intakeofironintheirdiettosupplytheirgreaterphysiologi-
cal necessities, since they also lose iron during menstrua-
tion (Eichner, 1998).
In this context, the general downward trend for eryth-
rocytes, hemoglobin and hematocrit after pequi-oil
supplementation was mainly related to plasma expansion
rather than to hemolysis, since this drop was accompanied
by significantly lower RDW and higher MCH and MCHC.
Because RDW is the most commonly reported index of the
variationordegreeofanisocytosisincellvolumewithinthe
red cell population (Zago et al., 2004), and erythrocytes are
prone to suffer from exercise-induced lipid oxidative dam-
age (Sureda et al., 2005), mechanical stress, and cytosolic
and extracellular pH changes (Petibois and Déléris, 2005),
the significant reduction in RDW values indicates that
pequi oil exerted protective effects on RBC. Moreover, af-
ter pequi-oil supplementation, RDW values returned to
theirnormalreferencevalues.Inaddition,whileMCHindi-
cates the average amount of oxygen-carrying hemoglobin
inside an RBC, MCHC indicates the mean concentration of
hemoglobin inside red cells (in respect to 1 dL of erythro-
cytes) (Zago et al., 2004). Both increased after supplemen-
tation. Thus, these results suggest that pequi oil improved
the blood oxygen-carrying capacity. However, except for
MCHC and RDW values, results were influenced by the
polymorphisms studied.
The Hp phenotypes determine the serum levels of the
Hp-glycoprotein,andtheydifferinplasmaconcentrationof
Hp and in antioxidant activities, besides others, presenting
different clinical consequences (Yano et al., 1998; Wassel,
2000; Tseng et al., 2004). Since various functional proper-
ties of Hp phenotypes have been described as a direct con-
sequence of protection against oxidative stress (Wassel,
2000; Guéye et al., 2006), our results suggest that the
higherHp2-1genotypefrequencycanbeassociatedwithan
improved capacity to carry oxygen, although intermediate
antioxidant activities between Hp1-1 and Hp2-212 have
been cited. Given that Hp2-2 presented the lowest MDA
values in TBARS assay, its lower frequency in the athlete
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Figure 1 - Influence of Haptoglobin (Hp), MnSOD (Val9Ala), CAT (-21A/T) and GPX1 (Pro198Leu) gene polymorphisms on erythrogram results be-
fore and after pequi-oil supplementation.Data are expressed as mean  SE (standard error of mean). Asterisks indicate significant (*p < 0.05) and highly
significant (**p < 0.01) differences in the comparison of before-after values by the T-test for dependent samples. The alphabet letters indicate significant
differences detected by Fisher’s LSD test between the variable’s categories (genotypes), as follow: Erythrocytes - for Hp a = significant compared to b
(p=0.03626),b=significantcomparedtoc(p=0.0015);forCATa=significantcomparedtob(p=0.0176)andc(p<0.0001),b=significantcompared
to c (p = 0.0030); Hemoglobin - for GPX1 a = significant compared to b (p = 0.0341); Hematocrit - for Hp a = significant compared to b (p = 0.0276),
b = significant compared to c (p = 0.0020); for MnSOD a = significant compared to c (p = 0.0016), b = significant compared to c (p = 0.0015); for CAT
a = significant compared to c (p = 0.0009), b = significant compared to c (p = 0.0030); MCV (mean cell volume) - for CAT a = significant compared to b
(p=0.0015)andc(p=0.0061);forGPX1a=significantcomparedtoc(p=0.0285),b=significantcomparedtoc(p=0.0061);andMCH(meancellhe-
moglobin) - for CAT a = significant compared to b (p = 0.0003) and c (p = 0.0006); for GPX1 a = significant compared to c (p = 0.0134), b = significant
compared to c (p = 0.0206).samples could be related to a lower degree of aerobic ca-
pacity in relation to the other genotypes.
MnSOD (EC 1.15.1.1, MIM *147460) is a mitochon-
drial enzyme that catalyzes the dismutation reaction of
superoxide radicals (O2
￿-) to hydrogen peroxide (H2O2)
(Hermes-Lima, 2004). It is encoded by a nuclear gene lo-
catedonchromosome6q25.3(Bastakietal.,2006).Theen-
zyme is synthesized with a mitochondrial targeting se-
quence (MTS), which drives its mitochondrial import. In
the mitochondrial matrix, the MTS is cleaved, and the ma-
tureproteinassemblesintotheactivetetramer(Akyoletal.,
2005). The valine to alanine substitution in MnSOD MTS
induces a conformational change from an -helix to a
-sheet, which has been reported to change mitochondrial
processingefficiency,affectthetransportofMnSODtothe
mitochondria, and to decrease MnSOD efficiency against
oxidative stress (Akyol et al., 2005). Given that the present
workwascarriedoutwithathletesandMnSODisunderse-
lective pressure, our results suggest that MnSOD hetero-
zygosis favours defence against oxidative stress. The
Val/Ala genotype presented the lowest lipid peroxidation
levels, whereas MnSOD Val/Val genotypes responded
better to pequi-oil supplementation.
Catalase (CAT, E.C.1.11.1.6, MIM +115500) is the
main regulator of hydrogen peroxide metabolism and its
high concentrations in erythrocytes provides a defence
against high concentrations of hydrogen peroxide (Góth et
al.,2004;Hermes-Lima,2004;Suredaetal.,2005;Ferreira
et al., 2007). Although CAT 21A/T polymorphism has not
been associated with any alteration in catalase activity
(Góth et al., 2004), individuals carrying a variant T allele
presented higher MCH values, suggesting superior effi-
ciency in oxygen transport. However, the best response to
pequi-oil treatment was presented by AA and AT geno-
types. These genotypes showed a significant decrease in
erythrocytes and hematocrit values after supplementation,
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Figure 2 - Influence of Haptoglobin (Hp) and MnSOD (Val9Ala) gene
polymorphisms on the results of TBARS assay before and after pequi-oil
supplementation. Data are expressed as mean  SE (standard error of
mean). Asterisks indicate highly significant (**p < 0.01) differences in
thecomparisonofbefore-aftervaluesbytheT-testfordependentsamples.
Letters indicate significant differences detected by Fisher’s LSD test be-
tween the variable’s categories (genotypes): for Hp a = significant com-
pared to b (p = 0.0185); for MnSOD a = significant compared to b
(p = 0.0032).
Table 6 - Distribution of Haptoglobin, MnSOD, CAT and GPX1 allele frequencies, genetic diversity parameters, genotype frequencies and Hardy-
Weinberg equilibrium (HWE) data for chi-square (	
2) test.
Alleles Allele
frequencies
Heterozygosity
-observed (Ho)
Heterozygosity
-expected (He)
Genotypes Genotype
frequencies
Number of observed
individuals
Number of ex-
pected individuals
HWE test
(p-values)
Haptoglobin Haptoglobin
Hp
*1 0.508 0.504 0.617 1-1 0.288 36 32.26
Hp
*2 0.492 0.504 0.617 2-1 0.440 55 62.49 0.2181
2-2 0.272 34 30.26
MnSOD MnSOD
Val 0.568 0.800 0.491 Val/Val 0.168 21 40.33
Ala 0.432 0.800 0.491 Val/Ala 0.800 100 61.34 0.0000
Ala/Ala 0.032 04 23.33
CAT CAT
A 0.396 0.424 0.478 AA 0.184 23 19.60
T 0.604 0.424 0.478 AT 0.424 53 59.80 0.1944
TT 0.392 49 45.60
GPX1 GPX1
Pro 0.688 0.400 0.429 Pro/Pro 0.488 61 59.17
Leu 0.312 0.400 0.429 Pro/Leu 0.400 50 53.66 0.5374
Leu/Leu 0.112 14 12.17
p-values data for heterozygote excess (*p = 0.0000) were generated using the statistical program Genepopweb version 3.4.but they also presented a significant increase in MCH val-
ues, confirming the previous suggestion that the general
downward trend for erythrocytes, hemoglobin and hemato-
critafterpequioilwasmainlyrelatedtoplasmaexpansion.
The antioxidant enzyme glutathione peroxidase 1
(GPX1, EC 1.11.1.9, MIM +138320) is part of the enzy-
matic antioxidant defence preventing oxidative damage to
biomolecules, by detoxifying hydrogen peroxide and or-
ganic hydroperoxides using glutathione in its reduced form
(GSH)asaco-substrate(Hermes-Lima,2004;Suredaetal.,
2005; Zhao et al., 2005; Ferreira et al., 2007). The GPX1
gene encoding the isoenzyme particularly abundant in
erythrocytes (Sureda et al., 2005; Zhao et al., 2005) and
some studies have indicated that a variant Leu allele affects
the GPX1 activity, which becomes less responsive to stim-
ulation. The increased risk of some kinds of cancer has also
been associated with variant Leu allele. However, such as-
sociations have not been consistently observed in all popu-
lations, since Leu allele frequency varies by ethnic group
(Zhao et al., 2005).
In the present study, although hemoglobin concentra-
tion in the Pro/Pro genotype proved to be significantly
lower than in the Pro/Leu, MCH values were similar to het-
erozygous Pro/Leu and these values were significantly
higher than those shown by Leu/Leu individuals. More-
over, only individuals carrying the Pro allele presented a
significant increase in MCH values after pequi-oil treat-
ment. These results suggest that subjects carrying the Pro
allelemaypresentahigherefficiencyofeachcellinoxygen
transport, besides having a better response to antioxidant
supplementation.
It is important to note that the antioxidant system,
working in parallel with exercise training, is a known in-
ducer of antioxidant enzymes. However, although regular
exercise causes adaptations, which reduce the incidence of
oxidative stress, increased antioxidant enzyme activities
are insufficient to completely eliminate the ROS produced
after intense exercise (Sureda et al., 2005; Ferreira et al.,
2007).Sincetheeliteathleteswhoparticipatedinthisstudy
covered distances of 6 km and more, influence of the dis-
tancecoveredisexpectedintheresultsofTBARSassay,as
well as a higher lipidic peroxidation for 4-5 km runners.
Nevertheless, after pequi-oil treatment, there was also a
significant increase in MCH and MCHC values (within the
reference values) at this distance, thereby corroborating the
previoussuggestionthatpequioilaidedinimprovingblood
oxygen-carrying capacity. Although the significant drop in
MDA values (TBARS assay) appeared only at the 6-7 km
mark after supplementation, there was also a decrease in
MDA values at the 8-10 and 16-21 km marks, thus indicat-
ing that pequi oil was biologically efficient in reducing
lipid peroxidation in trained athletes.
Moreover, it has been suggested that when trained
athletes run a comparatively short distance, alterations in
erythrocyte antioxidant status may occur even though plas-
ma indices of lipid peroxidation are unaffected (Duthie et
al., 1990). Our results are in accordance with this sugges-
tion; they also indicate differences in response that depend
on gender, since after pequi-oil supplementation no effect
was observed in lipid peroxidation among females, despite
significant improvements in RBC parameters. However,
except for MCHC and RDW values, results were influ-
enced by the polymorphisms studied.
Insummary,ourresultssuggestthatpequioilaidedin
improvingbothexercise-inducedanisocytosisinrunnersas
well as blood oxygen-carrying capacity. However, except
forMCHCandRDWvalues,theresultswereinfluencedby
the genetic background. The best response to pequi-oil
treatment was presented by subjects carrying MnSOD
Val/Valgenotype,CATAAorATgenotypeandGPX1Pro
allele. Therefore, pequi oil, as well as possessing many
other nutritional properties, is a good candidate for use as
an antioxidant supplement.
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